The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathy

Abstract excerpt

INTRODUCTION: Diabetic cardiomyopathy (DCM) is an end-point macrovascular complication associated with increased morbidity and mortality in 12% of diabetic patients. MicroRNAs (miRNAs) are small noncoding RNAs that can act as cardioprotective or cardiotoxic agents in DCM. METHODS: We used PubMed as a search engine to collect and analyse data in published articles on the role of miRNAs on the pathophysiology,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apelin-related biomedical research
• Share to Cardiovascular Function and Risk Factors
• Share to MicroRNA in disease regulation